ASH 2024 Summary: Highlights in Bone Marrow Failure Disorders

2024 ASH Annual Meeting Insights Hub

P. Scheinberg

Thrombosis in Patients With ITP

Platelet Disorder Support Association (PDSA)

H. Liebman

Misinformation in ITP

Platelet Disorder Support Association (PDSA)

D. Nugent

ASH 2024 Review: New Therapies in ITP

Cleveland Clinic Taussig Cancer Institute

A. Hubben

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Initial Approach and Considerations for Management of ITP

Nicoletta Machin

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Management of Treatment-Naive ITP Patients

Weill Cornell Medicine Oncology & Hematology

J. Bussel

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Teenagers and ITP

Platelet Disorder Support Association (PDSA)

N. Cooper

Are All New ITP Treatments Better Than Old Ones: Other Treatments to…

Platelet Disorder Support Association (PDSA)

H. Liebman

Natural History of ITP: Navigating the Journey

Platelet Disorder Support Association (PDSA)

D. Kuter

Where Does Rituximab Fit in ITP

Platelet Disorder Support Association (PDSA)

D. Nugent

Management of iTTP

Yazan Abou-Ismail

Causes of Secondary ITP and Long-Term Risk of Other Diseases in ITP …

Platelet Disorder Support Association (PDSA)

D. Kuter

Evolving Treatment Landscape in ITP

Robert Bird